$7.38
0.162.22%
At close: -
$7.48
0.101.36%
After Hours: Dec 20, 7:59 PM EDT
Comments
Loading...
Iovance Biotherapeutics (IOVA) Forecast
NewsEarningsIovance Biotherapeutics (IOVA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestIovance Biotherapeutics (NASDAQ:IOVA) Stock Quotes, Forecast and News Summary
Iovance Biotherapeutics Stock (NASDAQ: IOVA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Iovance Biotherapeutics (IOVA) stock?
You can purchase shares of Iovance Biotherapeutics (NASDAQ:IOVA) through any online brokerage.
Who are Iovance Biotherapeutics (IOVA) competitors?
Other companies in Iovance Biotherapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for Iovance Biotherapeutics (IOVA) stock?
Iovance Biotherapeutics has a consensus price target of $21.18.
What is the current price for Iovance Biotherapeutics (IOVA)?
The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $7.4806 last updated December 20, 2024 at 7:59 PM EST.
Does Iovance Biotherapeutics (IOVA) pay a dividend?
There are no upcoming dividends for Iovance Biotherapeutics.
When is Iovance Biotherapeutics (NASDAQ:IOVA) reporting earnings?
Iovance Biotherapeutics’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Iovance Biotherapeutics (IOVA) going to split?
There is no upcoming split for Iovance Biotherapeutics.
What sector and industry does Iovance Biotherapeutics (IOVA) operate in?
Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.